The AI safety community acknowledges it lacks all the ideas needed to ensure a safe transition to AGI. This creates an imperative to fund 'neglected approaches'—unconventional, creative, and sometimes 'weird' research that falls outside the current mainstream paradigms but may hold the key to novel solutions.

Emmett Shear reframes AI alignment away from a one-time problem to be solved. Instead, he presents it as an ongoing, living process of recalibration and learning, much like how human families or societies maintain cohesion. This challenges the common 'lock in values' approach in AI safety.

Research with long timelines (e.g., a "2063 scenario") is still worth pursuing, as these technical plans can be compressed into a short period by future AI assistants. Seeding these directions now raises the "waterline of understanding" for future AI-accelerated alignment efforts, making them viable even on shorter timelines.

OpenAI's health division serves a dual purpose: delivering societal benefits and providing a real-world, high-stakes environment for AI safety research. Problems like scalable oversight (supervising superhuman AI) move from theoretical exercises to practical necessities when models outperform physicians on narrow tasks, creating concrete feedback loops that accelerate safety progress.

Unlike specialized non-profits, Far.AI covers the entire AI safety value chain from research to policy. This structure is designed to prevent promising safety ideas from being "dropped" between the research and deployment phases, a common failure point where specialized organizations struggle to hand off work.

Instead of building a single, monolithic AGI, the "Comprehensive AI Services" model suggests safety comes from creating a buffered ecosystem of specialized AIs. These agents can be superhuman within their domain (e.g., protein folding) but are fundamentally limited, preventing runaway, uncontrollable intelligence.

Ryan Kidd argues that it's nearly impossible to separate AI safety and capabilities work. Safety improvements, like RLHF, make models more useful and steerable, which in turn accelerates demand for more powerful "engines." This suggests that pure "safety-only" research is a practical impossibility.

An FDA-style regulatory model would force AI companies to make a quantitative safety case for their models before deployment. This shifts the burden of proof from regulators to creators, creating powerful financial incentives for labs to invest heavily in safety research, much like pharmaceutical companies invest in clinical trials.

The UK's AI Safety Institute (AISI) has two core functions. It channels research on frontier AI risks to UK and allied governments. It also actively mitigates threats by red-teaming models for developers and helping to drive real-world defenses like pandemic preparedness.